Electrocardiographic and hemodynamic effects of Panax ginseng

OBJECTIVE: To determine whether Panax ginseng ingestion can acutely or chronically alter electrocardiographic parameters: PR, QRS, QT, QTc, and RR intervals, and QT and QTc interval dispersion. Effects of P. ginseng on blood pressure and heart rate also were evaluated. METHODS: This is a prospective, randomized, double-blind, placebo-controlled study of healthy adults at the University of Connecticut. Thirty subjects were randomly allocated to receive 28 days of therapy with either P. ginseng extract 200 mg or placebo. Baseline 12-lead electrocardiograms (ECGs) were obtained. Subsequent ECGs were performed following study drug ingestion at 50 minutes, 2 hours, and 5 hours on days 1 and 28. Blood pressure readings were taken with each ECG. RESULTS: P. ginseng ingestion increased the QTc interval by 0.015 seconds on day 1 at 2 hours compared with the placebo group (p = 0.03). It also reduced diastolic blood pressure from 75 +/- 5 mm Hg at baseline to 70 +/- 6 mm Hg at the same time point (p = 0.02). The observed effects are not believed to be clinically significant. No other statistically significant changes were found in electrocardiographic or hemodynamic variables on days 1 or 28. CONCLUSIONS: P. ginseng, at doses of 200 mg of the extract daily, increases the QTc interval and decreases diastolic blood pressure 2 hours after ingestion in healthy adults on the first day of therapy.

This article has been cited by other articles:

				S. A. Shah, L. Schlesselman, D. Cios, J. Lipeika, A. A. Patel, J. Kluger, and C. M. White Effects of echinacea on electrocardiographic and blood pressure measurements Am. J. Health Syst. Pharm., August 1, 2007; 64(15): 1615 - 1618. [Abstract] [Full Text] [PDF]

				S. A Shah, S. Sander, D. Cios, J. Lipeika, J. Kluger, and C M. White Electrocardiographic and Hemodynamic Effects of Coenzyme Q10 in Healthy Individuals: A Double-Blind, Randomized Controlled Trial Ann. Pharmacother., March 1, 2007; 41(3): 420 - 425. [Abstract] [Full Text] [PDF]

				P. M. Stavro, M. Woo, L. A. Leiter, T. F. Heim, J. L. Sievenpiper, and V. Vuksan Long-Term Intake of North American Ginseng Has No Effect on 24-Hour Blood Pressure and Renal Function Hypertension, April 1, 2006; 47(4): 791 - 796. [Abstract] [Full Text] [PDF]

				C. Buettner, G. Y Yeh, R. S Phillips, M. A Mittleman, and T. J Kaptchuk Systematic Review of the Effects of Ginseng on Cardiovascular Risk Factors Ann. Pharmacother., January 1, 2006; 40(1): 83 - 95. [Abstract] [Full Text] [PDF]

				C. M. White and B. F. McBride Electrocardiographic Effects of a Dietary Supplement Containing Ephedra and Caffeine--Reply JAMA, September 28, 2005; 294(12): 1487 - 1488. [Full Text] [PDF]

				B. Min, B. F. McBride, M. J. Kardas, A. Ismali, V. Sinha, J. Kluger, and C. M. White Hemodynamic impact of an ephedra-free multicomponent weight-loss supplement Am. J. Health Syst. Pharm., August 1, 2005; 62(15): 1582 - 1585. [Abstract] [Full Text] [PDF]

				P. M. Stavro, M. Woo, T. F. Heim, L. A. Leiter, and V. Vuksan North American Ginseng Exerts a Neutral Effect on Blood Pressure in Individuals With Hypertension Hypertension, August 1, 2005; 46(2): 406 - 411. [Abstract] [Full Text] [PDF]

				T.-K. Lee, R. M. Johnke, R. R. Allison, K. F. O'Brien, and L. J. Dobbs Jr Radioprotective potential of ginseng Mutagenesis, July 1, 2005; 20(4): 237 - 243. [Abstract] [Full Text] [PDF]

				I. Martinez-Mir, E. Rubio, F. J Morales-Olivas, and V. Palop-Larrea Transient ischemic attack secondary to hypertensive crisis related to Panax ginseng Ann. Pharmacother., November 1, 2004; 38(11): 1970 - 1970. [Full Text] [PDF]

				B. F. McBride, A. K. Karapanos, A. Krudysz, J. Kluger, C. I. Coleman, and C. M. White Electrocardiographic and Hemodynamic Effects of a Multicomponent Dietary Supplement Containing Ephedra and Caffeine: A Randomized Controlled Trial JAMA, January 14, 2004; 291(2): 216 - 221. [Abstract] [Full Text] [PDF]

				Y. S. Chang, E.-K. Seo, C. Gyllenhaal, and K. I. Block Panax ginseng: Panax ginseng: A Role in Cancer Therapy? Integr Cancer Ther, March 1, 2003; 2(1): 13 - 33. [Abstract] [PDF]